ASND
Ascendis Pharma A/S
Stock
$227.87+0.56 (+0.25%)Close Oct 2, 2026
Balance sheet
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | €616M | €560M | €392M | €445M | €446M | €585M | €598M | €278M | €195M | €180M | €120M |
| Inventory | €302M | €296M | €209M | €131M | €75M | €0 | — | — | — | — | — |
| Current assets | €1.1B | €1.1B | €703M | €923M | €806M | €740M | €611M | €293M | €205M | €184M | — |
| Goodwill | — | — | — | — | — | — | €3.5M | €3.5M | €3.5M | €3.5M | — |
| Total assets | €1.3B | €1.2B | €826M | €1.1B | €1.1B | €980M | €677M | €319M | €211M | €190M | — |
| Current liabilities | €1.1B | €908M | €737M | €717M | €100M | €53M | €48M | €39M | €24M | €13M | — |
| Long-term debt | €385M | €365M | €223M | €95M | €98M | — | — | — | — | — | — |
| Total liabilities | €1.5B | €1.3B | €971M | €826M | €201M | €141M | €80M | €39M | €24M | €13M | — |
| Shareholders' equity | −€163M | −€106M | −€146M | €263M | €884M | €839M | €597M | €280M | €187M | €177M | €120M |
| Shares outstanding | 62.0M | 60.7M | 57.7M | 57.2M | 56.9M | 53.8M | 48.0M | 42.1M | 37.0M | — | — |
| Current ratio | 1.04 | 1.17 | 0.95 | 1.29 | 8.03 | 14.02 | 12.74 | 7.53 | 8.61 | 13.67 | — |